Publications en collaboration avec des chercheurs de University of Oxford (82)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. EMAS position statement: Testosterone replacement therapy in older men

    Maturitas, Vol. 178

  3. Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials

    Thrombosis Research, Vol. 230, pp. 27-32

  4. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  5. GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors

    American Journal of Psychiatry

  6. Longitudinal change in neurocognitive functioning in children and adolescents at clinical high risk for psychosis: a systematic review

    European Child and Adolescent Psychiatry

  7. Rodent Animal Models of Endometriosis-Associated Pain: Unmet Needs and Resources Available for Improving Translational Research in Endometriosis

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

2022

  1. Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors

    Biological psychiatry, Vol. 91, Núm. 3, pp. 313-327

  2. Identification of Altered Evoked and Non-Evoked Responses in a Heterologous Mouse Model of Endometriosis-Associated Pain

    Biomedicines, Vol. 10, Núm. 2

  3. Iron-induced cytotoxicity mediated by endolysosomal TRPML1 channels is reverted by TFEB

    Cell Death and Disease, Vol. 13, Núm. 12

  4. Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical options

    Updates in Surgery, Vol. 74, Núm. 1, pp. 325-335

  5. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

  6. Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer

    Science Translational Medicine, Vol. 14, Núm. 660

  7. Scientists Against War: A Plea to World Leaders for Better Governance

    Sleep and Vigilance

  8. Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial

    The Lancet Haematology, Vol. 9, Núm. 8, pp. e594-e604

2021

  1. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

    BMC Infectious Diseases, Vol. 21, Núm. 1

  2. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  3. Preclinical models of endometriosis and interstitial cystitis/bladder pain syndrome: An Innovative Medicines Initiative-PainCare initiative to improve their value for translational research in pelvic pain

    Pain, Vol. 162, Núm. 9, pp. 2349-2365

  4. SARS-CoV-2 neutralising antibody testing in Europe: Towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data

    Eurosurveillance, Vol. 27

  5. Selective modulation by PARP-1 of HIF-1α-recruitment to chromatin during hypoxia is required for tumor adaptation to hypoxic conditions

    Redox Biology, Vol. 41